HOME >> MEDICINE >> NEWS
Angioplasty clears clogged brain arteries

SAN DIEGO, Feb. 5 Angioplasty opened narrowed brain arteries, preventing strokes in patients for whom standard medication had failed, according to a study presented today at the American Stroke Association's 29th International Stroke Conference.

"Angioplasty improves the outcome over what we would expect to see with medication alone," said study author Michael P. Marks, M.D., associate professor of radiology and neurosurgery and chief of interventional neuroradiology at Stanford University Medical Center in Palo Alto, Calif. Additionally, "Stent treatment may not be necessary."

The study was not a head-to-head comparison of angioplasty and medical therapy. Researchers used data from other studies to make risk comparisons.

Angioplasty uses a tiny balloon threaded into the area of blockage. Once in this area, the balloon is inflated. As it expands, it forces the fatty plaque against the artery wall, opening the vessel. Balloon angioplasty is widely used to open blocked heart arteries but is not as commonly used for clearing neck and brain arteries. In some cases, a miniature wire tube called a stent is left behind after angioplasty to keep the artery propped open.

Blood thinners such as aspirin and anticoagulants such as warfarin are standard medical therapy for clogged brain vessels. Anticoagulants interfere with the blood's ability to clot.

The study examined both the overall rate of stroke and the rate of stroke in areas supplied by the treated vessel in patients with symptomatic intracranial stenosis (narrowing of a brain blood vessel) undergoing angioplasty.

Researchers studied 36 patients with significant intracranial stenosis, all of whom had unsuccessful medical therapy. Before angioplasty stenosis averaged 84.2 percent. After angioplasty, stenosis averaged 43.3 percent.

One ischemic stroke occurred during angioplasty but the patient recovered. No other ischemic strokes occurred within one month of angi
'"/>

Contact: Carole Bullock
carole.bullock@heart.org
214-706-1279
American Heart Association
5-Feb-2004


Page: 1 2

Related medicine news :

1. Angioplasty, robotically assisted keyhole bypass combo appears effective
2. Angioplasty safer, need for emergency surgery afterward plunges
3. Angioplasty or medical therapy immediately after heart attack?
4. Pairing Two Drugs With Angioplasty May Offer Best Success In Treating Heart Attacks
5. "Super Aspirin" Holds Long-Term Benefits For Some Patients Who Undergo Balloon Angioplasty
6. Laser Shown Effective In Patients Who Are Not Candidates For Bypass Surgery Or Angioplasty
7. New anti-inflammatory drug clears Alzheimers provoking protein from brains of mice
8. Novel anti-coagulant clears hurdle
9. Drug combination opens clogged arteries faster, keeps them open longer
10. Bone marrow cell transplant treats clogged leg arteries
11. Angiogenesis reduces leg pain from clogged arteries

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Angioplasty clears clogged brain arteries

(Date:1/22/2015)... Liberty University has received accreditation for its ... the Council for Accreditation of Counseling & Related Educational ... Center for Counseling & Family Studies , is under the ... new School of Behavioral Sciences. Prior to the formation of ...
(Date:1/22/2015)... AZ (PRWEB) January 22, 2015 Padre Murphy's ... long supporter of Pro Player Health Alliance (PPHA). ... Padre Murphy's in getting everyone, including NFL greats, treated for ... of the leading groups supporting the cause in the valley. ...
(Date:1/22/2015)... January 23, 2015 AngelWeddingDress, the premier ... 2015 maternity wedding dresses. View website of ... looking for maternity wedding dresses online for a bridal ... with high quality for them. Its maternity wedding dresses ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Autocarinsurancebest.com has released ... purchasing a commercial auto insurance policy . , Auto ... their vehicles. It is no longer necessary to call an ... are now available online on a single website: http://autocarinsurancebest.com/ ...
(Date:1/22/2015)... Yesterday, Senator Holly Mitchell (D-Los ... Olsen (R-Modesto) were honored by the California Healthcare ... biomedical science, medical device and pharmaceutical innovation in ... “2014 Life Sciences Champion” award from CHI President ...
Breaking Medicine News(10 mins):Health News:Liberty University's Resident Master’s Counseling Program Receives CACREP Accreditation 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3
(Date:1/23/2015)... EAST SETAUKET, N.Y. , Jan. 23, 2015  Lixte Biotechnology ... sites where its Phase I trial of Lixte,s lead compound, ... 5 institutions. John S. Kovach , M.D., ... trial was planned to be completed at a single site. ...
(Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ CM: ... CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation ... receipt of $385,642, net of transaction costs, in ... Technology Business Tax Certificate Transfer Program sponsored by ...
(Date:1/23/2015)... BOSTON , January 23, 2015 ... development company, is delighted to announce that the Malcolm ... Miles Congreve (Vice President of Chemistry), Fiona ... Weir (Chief Executive Officer and co-founder) for the seminal ...
Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4
Cached News: